Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
6 studies found for:    Open Studies | "Gangrene"
Show Display Options
Rank Status Study
1 Recruiting Modulation of Biomarkers in Patients With Flesh-eating Bacterial Infections After With Hyperbaric Oxygen Treatment
Conditions: Necrotizing Soft Tissue Infection;   Necrotizing Fasciitis;   Gas Gangrene;   Fournier Gangrene
2 Recruiting Treatment of Chronic Critical Limb Ischemia With G-CSF-mobilized Autologous Peripheral Blood Mononuclear Cells
Conditions: Critical Limb Ischemia;   Atherosclerosis;   Ischemic Ulcer;   Gangrene
Intervention: Biological: Peripheral blood mononuclear cell
3 Recruiting Phase III Efficacy and Safety Study of AB103 in the Treatment of Patients With Necrotizing Soft Tissue Infections
Conditions: Necrotizing Soft Tissue Infections;   Necrotizing Fasciitis;   Fournier's Gangrene
Interventions: Drug: AB103 0.5 mg/kg;   Other: NaCl 0.9%
4 Unknown  Safety and Efficacy of Autologous Bone Marrow Stem Cells for Lower Extremity Ischemia Treating
Conditions: Lower Extremity Ischemia;   Leg Ulcer;   Peripheral Vascular Disease;   Diabetic Foot;   Gangrene
Intervention: Procedure: BM-MNC injection
5 Recruiting Autologous Adipose-Derived Stromal Cell Delivered Via Intramuscular Injections for the Treatment of Critical Limb Ischemia
Condition: Critical Limb Ischemia
Interventions: Procedure: Liposuction;   Other: Stem Cell Injection
6 Recruiting Best Endovascular vs. Best Surgical Therapy in Patients With Critical Limb Ischemia
Condition: Critical Limb Ischemia
Interventions: Procedure: Open surgical revascularization;   Device: Endovascular revascularization

Indicates status has not been verified in more than two years